Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2

Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2

Keywords: Evidence-based medicine, COVID-19, Hydroxychloroquine, Pandemic, RCT, SARS

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care (London, England) England), 2020-04, Vol.24 (1), p.182-182, Article 182
Hauptverfasser: Ingraham, Nicholas E, Boulware, David, Sparks, Matthew A, Schacker, Timothy, Benson, Bradley, Sparks, Jeffrey A, Murray, Thomas, Connett, John, Chipman, Jeffrey G, Charles, Anthony, Tignanelli, Christopher J
Format: Artikel
Sprache:eng
Schlagworte:
Analysis
Antibiotics
Betacoronavirus - drug effects
Clinical trials
Coronavirus Infections - drug therapy
Coronaviruses
COVID-19
Critical care
Drug overdose
Epidemics
Evidence-based medicine
Financial markets
Health aspects
Humans
Hydroxychloroquine
Hydroxychloroquine - therapeutic use
Pandemic
Pandemics
Pneumonia, Viral - drug therapy
RCT
SARS
Severe acute respiratory syndrome coronavirus 2
Social networks
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Keywords: Evidence-based medicine, COVID-19, Hydroxychloroquine, Pandemic, RCT, SARS
ISSN:1364-8535
1466-609X
1364-8535
1366-609X
DOI:10.1186/s13054-020-02894-7